You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Genotype

Showing 26 - 50 of 4,593
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CYP3A4*22 Trial (Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet)

Not yet recruiting
  • CYP3A4*22
  • Palbociclib 125Mg Tab
  • +2 more
  • (no location specified)
Jan 10, 2023

Hereditary Hemorrhagic Telangiectasia, HHT, Rendu Osler Weber Disease Trial in Madrid (Registry)

Recruiting
  • Hereditary Hemorrhagic Telangiectasia
  • +2 more
  • Registry
  • Madrid, Spain
    Hospital Universitario Ramón y Cajal
Sep 30, 2022

UGT1A1 Genotyping in Taiwanese Cancer Patients

Not yet recruiting
  • The Influence of the UGT1A1 Genotype
    • (no location specified)
    Mar 20, 2023

    Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

    Completed
    • Chronic Hepatitis c Genotype 1
    • Moscow, Russian Federation
    • +4 more
    Oct 27, 2022

    Phenotype, Genotype and Biomarkers 2

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • +4 more
      • Miami, Florida
      • +3 more
      Dec 19, 2022

      Glucose, Circadian Rhythm, Melatonin Trial in Boston (melatonin, )

      Completed
      • Glucose
      • +3 more
      • melatonin
      • placebo
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jul 22, 2022

      CYP1A2 Polymorphism Trial in Poznan (Intervention group with genotype information, Control group without genotype information)

      Completed
      • CYP1A2 Polymorphism
      • Intervention group with genotype information
      • Control group without genotype information
      • Poznań, Poland
        Poznan University of Life Sciences
      Feb 17, 2022

      Cleidocranial Dysplasia: From Genotype to Phenotype and

      Enrolling by invitation
      • Cleidocranial Dysostosis
        • Baltimore, Maryland
          Johns Hopkins University
        May 6, 2022

        Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

        Enrolling by invitation
        • Bardet-Biedl Syndrome
        • No intervention
        • Oslo, Norway
          Oslo University Hospital
        May 29, 2022

        Diffuse Large B Cell Lymphoma Trial (Rituximab, Cyclophosphamide, Doxorubicin)

        Not yet recruiting
        • Diffuse Large B Cell Lymphoma
        • (no location specified)
        Apr 24, 2022

        Angelman Syndrome Trial (60 mg QD Alogabat, 40 mg QD Alogabat, 7 mg QD Alogabat)

        Not yet recruiting
        • Angelman Syndrome
        • 60 mg QD Alogabat
        • +4 more
        • (no location specified)
        Feb 1, 2023

        Atrial Fibrillation, Valvular Heart Disease Trial in Beijing (Gene-directed dosage of warfarin, standard dosage of warfarin)

        Completed
        • Atrial Fibrillation
        • Valvular Heart Disease
        • Gene-directed dosage of warfarin
        • standard dosage of warfarin
        • Beijing, Beijing, China
          Chinese Academy of Medical Sciences Fuwai Hospital
        Apr 28, 2022

        Antithrombin III Deficiency Trial in Brussel (observation)

        Not yet recruiting
        • Antithrombin III Deficiency
        • observation
        • Brussel, Belgium
          UZ Brussel
        May 26, 2023

        That Distinguish Between Tofacitinib Responders and

        Completed
        • Ulcerative Colitis
        • GWAS analysis by Illumina BeadChip
        • New York, New York
          New York University School of Medicine
        Aug 9, 2022

        Primary Ciliary Dyskinesia Trial in Chapel Hill (Albuterol, Technetium99m - Sulfur Colloid (Tc99m-SC))

        Recruiting
        • Primary Ciliary Dyskinesia
        • Albuterol
        • Technetium99m - Sulfur Colloid (Tc99m-SC)
        • Chapel Hill, North Carolina
          University of North Carolina Chapel Hill
        Aug 10, 2022

        Healthy Lifestyle, Taste Disorders, Diet Habit Trial in Poznan (Intervention genotype personalized nutritional recommendations,

        Completed
        • Healthy Lifestyle
        • +2 more
        • Intervention genotype personalized nutritional recommendations
        • +2 more
        • Poznań, Poland
          Poznan University of Life Sciences
        Jul 7, 2022

        Genetic Diagnosis in Congenital Cataracts

        Completed
        • Congenital Cataract
        • Ophthalmic examination
        • Whole-exome sequencing
        • Guangzhou, Guangdong, China
          Zhongshan Ophthalmic Center, Sun Yat-sen University
        Mar 12, 2023

        Asthma Trial in United States (Dupilumab, Placebo)

        Recruiting
        • Asthma
        • Boston, Massachusetts
        • +6 more
        Dec 5, 2022

        Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

        Completed
        • Hepatitis C
        • Bradford, United Kingdom
        • +3 more
        Jan 4, 2023

        Hereditary Haemorrhagic Telangiectasia Trial in Bron, Clermont-Ferrand, Montpellier (Cord blood sampling, Cord sampling)

        Not yet recruiting
        • Hereditary Haemorrhagic Telangiectasia
        • Cord blood sampling
        • Cord sampling
        • Bron, France
        • +2 more
        Nov 21, 2022

        Vascular Stains to Optimize Treatment Utilizing Optical

        Recruiting
        • Vascular Stains
        • Optical Coherence Tomography (OCT)
        • Irvine, California
        • +1 more
        Apr 15, 2022

        Dystonia Genotype-Phenotype Correlation

        Recruiting
        • Dystonia
        • +21 more
        • Magnetic Resonance Imaging
        • Dallas, Texas
          University of Texas Southwestern Medical Center
        Jun 30, 2022

        Plasma Genotyping asNoninvasive Biomarker for Genotype-directed

        Recruiting
        • NSCLC
        • Melanoma
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Mar 1, 2022

          Pathogenic Mechanism in Hereditary Ataxia

          Recruiting
          • Hereditary Ataxia
            • Hangzhou, Zhejiang, China
              Second Affiliated Hospital, Zhejiang University School of Medici
            Dec 22, 2021

            Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)

            Not yet recruiting
            • Coronary Artery Disease
            • Platelet Reactivity
            • (no location specified)
            Mar 7, 2023